news aktuell GmbH

Bertrandt AG: Bertrandt strengthens its expertise in the mega trends of the automotive and aviation sectors with the acquisition of the Philotech Group

Share

Bertrandt is consistently advancing its group strategy. With the acquisition of the specialist company Philotech, it is further expanding the growth fields of software, electronics, and IT security.

(Ehningen, Germany): – For around 35 years now, the Philotech Group has been a specialist for highly demanding, holistic development projects in the fields of software, electronics, and IT security. It provides comprehensive solutions for complex systems for customers from the aviation, automotive, telecommunications, and transportation sectors. In the field of aviation, its core competencies include, for example, flight control systems, avionics systems, and softwaredevelopment, as well as their integration and validation. In the automotive sector, the focus is on autonomous systems, electric mobility and connectivity. 

With its know-how and its regional and internationaloperations at sites in Germany, France and Spain, the Philotech Group complements not only Bertrandt’s broad and deep range of services, but also its regional organization.   

“We are very pleased to be able to expand Bertrandt’s range of services with the acquisition of the Philotech Group. Together, we can meet our customers’ requirements in the best possible way. The expansion of our activities in the growth areas of the mobility industry is an important component in Bertrandt’s group strategy” says Michael Lücke, Member of the Board of Bertrandt AG. 

“After intensive analyses of potential partners, we see the best prospects with Bertrandt. We are convinced that we will be able to take advantage of the great growth opportunities in the future-oriented developments in aerospace, automotive, and telecommunications together. I am also pleased to be offering the employees of Philotech further perspectives in the increasingly complex and larger requirements of our clients" says Hartwig Dirscherl, Managing Director of the Philotech Group. 

The Philotech Group has been very successful in recent years in the cross-sector transformation of its competencies. The closing of the transaction is largely dependent on antitrust approval and is expected for the first quarter of 2022. 

No details have been disclosed regarding the agreed purchase price.

About Bertrandt
As a leading development service provider in the automotive, aerospace, and mechanical engineering sectors, Bertrandt focuses on providing top-quality, technology-oriented services for the mobility of today and tomorrow. The trends of digitalization, autonomous systems, connectivity, and electric mobility play a key role in this.

Our almost 50 years of cross-sector expertise and our global presence enable us to develop customer-focused solutions quickly and efficiently. Our strengths lie in our ability to implement projects from a holistic perspective – from the initial consultation to final implementation and validation, including start of production and after sales – as well as the speed at which we are able to scale up projects. Around 12,000 employees at more than 50 sites worldwide are committed to addressing the challenges faced by our customers.

About Philotech
Philotech provides engineering and consulting services for demanding and safety-critical applications. Its targeted customers are manufacturers and suppliers in these sectors.

We have accumulated in-depth competencies on an international level. Our customers have regarded the owner-managed company Philotech as their preferred engineering and consulting partner for more than 30 years.

Highly qualified and motivated engineers are working at our headquarters and branches in Germany as well as at our subsidiaries and at customer sites in Germany, France, Spain, and the United Kingdom. Their expertise is constantly being fostered by an internal know-how transfer as well as by close cooperation with universities and research institutions.

www.bertrandt.com

Contacts

About news aktuell GmbH

news aktuell GmbH
news aktuell GmbH
Mittelweg 144
20148 Hamburg

+49 (0)40 4113-32589http://www.newsaktuell.de

As wholly owned subsidiary of dpa, news aktuell provides business and organizations with effective access to media and consumers. Via the smart tools ots and zimpel, PR content accesses all media formats, including classical print, high click-rate online portals and social networks. In addition, news aktuell publishes all its customers’ PR content on www.presseportal.de, one of the PR portals with the greatest reach in Germany. By this means, all the relevant multipliers are reached globally, from editors, via digital influencers right up to specialist bloggers and interested consumers. news aktuell has been on the market since 1989. The company, with a staff complement of more than 135, has its headquarters in Hamburg. Other offices are in Berlin, Dusseldorf, Frankfurt und Munich.

Subscribe to releases from news aktuell GmbH

Subscribe to all the latest releases from news aktuell GmbH by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from news aktuell GmbH

Grünenthal to license osteoarthritis pain treatment to Shionogi in Japan in deal of up to > $ 500 million4.8.2022 09:00:00 CEST | Pressemelding

(Aachen, Germany) Grünenthal and Shionogi announced today that they have entered into a licensing agreement for Grünenthal’s investigational medicine Resiniferatoxin (“RTX”). Shionogi obtained the exclusive rights to commercialise Grünenthal’s asset in Japan for pain associated with osteoarthritis of the knee. RTX is currently in Phase III of clinical development for the treatment of patients with moderate to severe pain associated with knee osteoarthritis. Osteoarthritis, a progressive and often painful joint disease, is an indication with high unmet medical need. If approved, RTX could become a well-tolerated, non-opioid therapy option for patients, providing long-lasting pain relief and functional improvement of the affected knee joints. Under the terms of the agreement, Shionogi will obtain the exclusive commercialisation rights for RTX in Japan for a total consideration of up to $ 525 million plus additional sales based payments. Thereof, Shionogi will pay $ 75 million upon signat

Make some noise for endangered species: Krombacher and Wacken Open Air present the "Growling Creatures" – the first metal band consisting of endangered animals1.8.2022 11:14:47 CEST | Pressemelding

(Krombach, Germany): What do grey seals, cuckoos, and lynx have in common? They are all rare, European native species whose survival is threatened, and they are part of the "Growling Creatures" - the first metal band consisting of endangered animals. Presented by Krombacher and the legendary metal festival Wacken Open Air (W:O:A), this summer the Growling Creatures are drawing attention to their threat and are making some noise for endangered species. "With Krombacher, we have long been committed to domestic and international species protection projects," says Peter Lemm, Head of Communications of the Krombacher brewery. "As a new partner of the Wacken Open Air, it was important for us to create an authentic connection between our sustainable commitment and entertainment with a twinkle in the eye. The Growling Creatures represent exactly this - as musical newcomers of the year, they deliver the best metal sound for the good cause." Animalistic Metal Sound On their mini-EP “Growling Cre

Avsender: R-Biopharm starts commercialization of the fully automated RIDA®UNITY system for real-time PCR in molecular diagnostic laboratories19.7.2022 08:36:55 CEST | Press release

(Darmstadt, Germany): As a fully integrated solution, the new and completely automated RIDA®UNITY system combines sample extraction, PCR setup, real-time PCR and result evaluation in a common workflow. The biotechnology company R-Biopharm AG announced today that it has received the CE mark and will begin selling the new, fully automated RIDA®UNITY system for molecular detection of infectious diseases throughout Europe. "With the RIDA®UNITY system, R-Biopharm is purposefully taking the path from a provider of individual solutions to a system provider in the field of molecular diagnostics," stated Christian Dreher, CEO of R-Biopharm. "We are very happy to make this system solution available to all molecular biology laboratories throughout Europe." Unique combination of different tools The RIDA®UNITY system combines the various steps in the analysis of patient samples into an integrated workflow – nucleic acid extraction, PCR setup, subsequent real-time PCR and the evaluation of the resul

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom